These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison of the performance of secretome analysis based on metabolic labeling by three unnatural sugars]. Mao Y; Zheng J; Feng S; Tian R Se Pu; 2021 Oct; 39(10):1086-1093. PubMed ID: 34505430 [TBL] [Abstract][Full Text] [Related]
3. Expanding the repertoire of GalNAc analogues for cell-specific bioorthogonal tagging of glycoproteins. Zafar A; Sridhar S; Bineva-Todd G; Cioce A; Abdulla N; Chang V; Malaker SA; Hewings DS; Schumann B RSC Chem Biol; 2024 Aug; 5(10):1002-9. PubMed ID: 39238612 [TBL] [Abstract][Full Text] [Related]
4. O-GalNAc incorporation into a cluster acceptor site of three consecutive threonines. Distinct specificity of GalNAc-transferase isoforms. Takeuchi H; Kato K; Hassan H; Clausen H; Irimura T Eur J Biochem; 2002 Dec; 269(24):6173-83. PubMed ID: 12473113 [TBL] [Abstract][Full Text] [Related]
6. O-linked N-acetylgalactosamine modification is present on the tumor suppressor p53. Xu Z; Ku X; Tomioka A; Xie W; Liang T; Zou X; Cui Y; Sato T; Kaji H; Narimatsu H; Yan W; Zhang Y Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129635. PubMed ID: 32417172 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the nucleotide triphosphate substrate specificity of Homo sapiens UDP-N-acetylgalactosamine pyrophosphorylase (AGX1). Xue M; Guan W; Zou Y; Fang J; Liu XW; Wang PG; Wang F Bioorg Med Chem Lett; 2012 Jun; 22(12):3957-61. PubMed ID: 22595178 [TBL] [Abstract][Full Text] [Related]
9. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions. Hanisch FG; Müller S; Hassan H; Clausen H; Zachara N; Gooley AA; Paulsen H; Alving K; Peter-Katalinic J J Biol Chem; 1999 Apr; 274(15):9946-54. PubMed ID: 10187769 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway. Pouilly S; Bourgeaux V; Piller F; Piller V ACS Chem Biol; 2012 Apr; 7(4):753-60. PubMed ID: 22276930 [TBL] [Abstract][Full Text] [Related]
11. Molecular evolution and functional divergence of UDP-hexose 4-epimerases. Fushinobu S Curr Opin Chem Biol; 2021 Apr; 61():53-62. PubMed ID: 33171387 [TBL] [Abstract][Full Text] [Related]
12. Metabolic glycoengineering through the mammalian GalNAc salvage pathway. Pouilly S; Piller V; Piller F FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230 [TBL] [Abstract][Full Text] [Related]
13. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases. Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772 [TBL] [Abstract][Full Text] [Related]
14. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851 [TBL] [Abstract][Full Text] [Related]
15. High level in vivo mucin-type glycosylation in Escherichia coli. Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634 [TBL] [Abstract][Full Text] [Related]
16. Core 1 O-N-acetylgalactosamine (O-GalNAc) glycosylation in the human cell nucleus. Cejas RB; Garay YC; de la Fuente S; Lardone RD; Irazoqui FJ Biol Chem; 2020 Aug; 401(9):1041-1051. PubMed ID: 32297877 [TBL] [Abstract][Full Text] [Related]
17. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant. Kingsley DM; Kozarsky KF; Hobbie L; Krieger M Cell; 1986 Mar; 44(5):749-59. PubMed ID: 3948246 [TBL] [Abstract][Full Text] [Related]
18. Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway. Boyce M; Carrico IS; Ganguli AS; Yu SH; Hangauer MJ; Hubbard SC; Kohler JJ; Bertozzi CR Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3141-6. PubMed ID: 21300897 [TBL] [Abstract][Full Text] [Related]
19. Large-scale site-specific mapping of the O-GalNAc glycoproteome. Yang W; Song A; Ao M; Xu Y; Zhang H Nat Protoc; 2020 Aug; 15(8):2589-2610. PubMed ID: 32681153 [TBL] [Abstract][Full Text] [Related]
20. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy. Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]